Nkarta (NKTX) Change in Accured Expenses (2019 - 2026)

Nkarta's quarterly Change in Accured Expenses came in at -$3.9 million in Q1 2026, down 2117.71% year-on-year from $192000.0 in Q1 2025, and down 253.37% quarter-over-quarter from $2.5 million in Q4 2025.

Nkarta has reported Change in Accured Expenses for 8 years, with the latest figure at -$3.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 2117.71% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (down 29.9% YoY), and the FY2025 full-year result was $2.5 million, up 155.11% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$3.9 million, down from $2.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.6 million in Q3 2022, with the low at -$3.9 million in Q1 2026.
  • Average Change in Accured Expenses over 5 years is $64705.9, with a median of $192000.0 recorded in 2025.
  • Year-over-year, Change in Accured Expenses soared 285.08% in 2023 and plunged 2117.71% in 2026.
  • Tracing NKTX's Change in Accured Expenses over 5 years: stood at -$619000.0 in 2022, then soared by 196.28% to $596000.0 in 2023, then tumbled by 512.08% to -$2.5 million in 2024, then soared by 202.85% to $2.5 million in 2025, then plunged by 253.37% to -$3.9 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$3.9 million (Q1 2026), $2.5 million (Q4 2025), and $448000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Nkarta 232.80 Mn 232.80 Mn - -3.87 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.87 Mn
Mar 31, 2026 -3.87 Mn
Dec 31, 2025 2.53 Mn
Dec 31, 2025 2.53 Mn
Sep 30, 2025 448,000.00
Sep 30, 2025 448,000.00
Jun 30, 2025 -703,000.00
Jun 30, 2025 -703,000.00
Mar 31, 2025 192,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 -2.46 Mn
Dec 31, 2024 -2.46 Mn
Sep 30, 2024 130,000.00
Sep 30, 2024 130,000.00
Jun 30, 2024 900,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 -3.04 Mn
Mar 31, 2024 -3.04 Mn
Dec 31, 2023 596,000.00
Dec 31, 2023 596,000.00
Sep 30, 2023 1.55 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 3.41 Mn
Jun 30, 2023 3.41 Mn
Mar 31, 2023 -1.33 Mn
Mar 31, 2023 -1.33 Mn
Dec 31, 2022 -619,000.00
Dec 31, 2022 -619,000.00
Sep 30, 2022 4.65 Mn
Sep 30, 2022 4.65 Mn
Jun 30, 2022 885,000.00
Jun 30, 2022 885,000.00
Mar 31, 2022 -2.16 Mn
Mar 31, 2022 -2.16 Mn
Dec 31, 2021 861,000.00
Dec 31, 2021 861,000.00
Sep 30, 2021 1.65 Mn
Sep 30, 2021 1.65 Mn
Jun 30, 2021 927,000.00
Jun 30, 2021 927,000.00
Mar 31, 2021 -642,000.00
Mar 31, 2021 -642,000.00
Dec 31, 2020 294,000.00
Dec 31, 2020 294,000.00
Sep 30, 2020 2.55 Mn
Sep 30, 2020 2.55 Mn
Jun 30, 2020 -453,000.00
Jun 30, 2020 -453,000.00
Mar 31, 2020 426,000.00
Mar 31, 2020 426,000.00
Dec 31, 2019 1.57 Mn
Dec 31, 2019 1.57 Mn
Sep 30, 2019 1.02 Mn
Sep 30, 2019 1.02 Mn